501 related articles for article (PubMed ID: 6757936)
21. [Conceptual aspects of myasthenia gravis].
Ledro Molina D; Avilés Mejías S; Garrido Peralta M
Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
[No Abstract] [Full Text] [Related]
22. [Thymectomy in myasthenia gravis].
Eckmann L
Schweiz Med Wochenschr; 1974 Jan; 104(3):74-7. PubMed ID: 4543947
[No Abstract] [Full Text] [Related]
23. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
[TBL] [Abstract][Full Text] [Related]
24. Myasthenia gravis: a clinical review.
Burke WJ
Clin Exp Neurol; 1981; 17():1-14. PubMed ID: 7346191
[No Abstract] [Full Text] [Related]
25. Pathogenesis and treatment of myasthenia gravis.
Scadding GK; Havard CW
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1008-12. PubMed ID: 6794741
[No Abstract] [Full Text] [Related]
26. [Myasthenia gravis].
Gajdos P
Rev Prat; 2002 Jan; 52(1):71-7. PubMed ID: 11852770
[No Abstract] [Full Text] [Related]
27. Myasthenia gravis, autoimmunity and the thymus.
Strauss AJ
Adv Intern Med; 1968; 14():241-80. PubMed ID: 4178674
[No Abstract] [Full Text] [Related]
28. Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
[TBL] [Abstract][Full Text] [Related]
29. Problems of immunology in myasthenia, polymyositis and Guillain-Barré syndrome.
Nisipeanu P
Rev Roum Neurol; 1973; 10(2):85-101. PubMed ID: 4209976
[No Abstract] [Full Text] [Related]
30. The treatment of patients with myasthenia gravis.
Sanders DB; Scoppetta C
Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
[TBL] [Abstract][Full Text] [Related]
31. [Myasthenia gravis: an autoimmune theory].
Uono M
Nihon Rinsho; 1973 Dec; 31(12):3387-93. PubMed ID: 4598899
[No Abstract] [Full Text] [Related]
32. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease.
De Baets MH
Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246
[TBL] [Abstract][Full Text] [Related]
33. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
34. [Juvenile myasthenia gravis].
Ohno K; Sahashi K
Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
[No Abstract] [Full Text] [Related]
35. Myasthenia gravis: the unmet needs of a paradigmatic autoimmune disease.
Modrego PJ
Neurodegener Dis Manag; 2018 Jun; 8(3):137-139. PubMed ID: 29943694
[No Abstract] [Full Text] [Related]
36. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis: an example of receptor disease.
Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
[No Abstract] [Full Text] [Related]
38. Myasthenia gravis. A clinical and basic science review.
Seybold ME
JAMA; 1983 Nov; 250(18):2516-21. PubMed ID: 6355534
[No Abstract] [Full Text] [Related]
39. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
Ohshima F
No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
[No Abstract] [Full Text] [Related]
40. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.
Olanow CW; Wechsler AS; Roses AD
Ann Surg; 1982 Aug; 196(2):113-21. PubMed ID: 7092360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
